Parkinson Disease
2 competing products in clinical development for Parkinson Disease.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| exidavnemab + Placebo Comparator | BioArctic AB | Phase 2 | Active | 49 |
| LY4006896 + Placebo | Eli Lilly | Phase 1 | Recruiting | 33 |